Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome

Prenatal Diagnosis

Volumn 17, Issue 11, 1997, Pages 1011-1018

  Kornman, L H ^a,b   Wortelboer, M J M ^a   Beekhuis, J R ^a   Morssink, L P ^a   Mantingh, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Ashford Cancer Centre   (Australia)

Author keywords

Down's syndrome; First trimester; Screening; Women's opinions

Indexed keywords

ADULT; ARTICLE; DOWN SYNDROME; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; ATTITUDE TO HEALTH; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; QUESTIONNAIRES;

EID: 0030693283     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199711)17:11<1011::AID-PD193>3.0.CO;2-1     Document Type: Article

References (35)

1. Abuelo, D.N., Hopmann, M.R., Barsel-Bowers, G., Goldstein, A. (1991). Anxiety in women with low maternal serum alpha-fetoprotein screening results, Prenat. Diagn., 11, 381-385.
2. Black, R.B. (1989). A 1 and 6 month follow-up of prenatal diagnosis patients who lost pregnancies, Prenat. Diagn., 9, 795-804.
3. Boué, J., Boué, A., Lazar, P. (1975). Retrospective and prospective epidemiological studies of 1500 karyotypes of spontaneous human abortions, Teratology, 12, 11-26.
4. Breed, A.S.P.M., Mantingh, A., Beekhuis, J.R., Kloosterman, M.D., ten Bolscher, H., Anders, G.J.P.A. (1990). The predictive value of cytogenetic diagnosis after CVS: 1500 cases, Prenat. Diagn., 10, 101-110.
5. Evans, M.I., Bottoms, S.F., Carlucci, T., Grant, J., Belsky, R.L., Solyom, A.E., Quigg, M.H., LaFerla, J.J. (1988). Determinants of altered anxiety after abnormal maternal serum α-fetoprotein screening, Am. J. Obstet. Gynecol., 159, 1501-1504.
6. Ferguson, J. (1993). Serum screening for Down syndrome at 16 weeks' gestation - maternal anxiety and pregnancy outcome. Commentary presented at the Australian Perinatal Society Meeting.
7. Firth, H.V., Boyd, P.A., Chamberlain, P., Mackenzie, I.Z., Lindenbaum, R.H., Huson, S.M. (1991). Severe limb abnormalities after chorionic villous sampling at 56-66 days' gestation, Lancet, i, 762-763.
8. Green, J. (1994). Women's experiences of prenatal screening and diagnosis. In: Abramsky, L., Chapple, J. (Eds). Prenatal Diagnosis. The Human Side, London: Chapman & Hall, 38-42.
9. Haddow, J.E., Palomaki, G.E., Knight, G.J., Cunningham, G.C., Lustig, L.S., Boyd, P.A. (1994). Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening, N. Engl. J. Med., 330, 1114-1118.
10. Iles, S. (1989). The loss of early pregnancy, Baillière's Clin. Obstet. Gynaecol., 3, 769-790.
11. Katz Rothman, B. (1988). The Tentative Pregnancy. Prenatal Diagnosis and the Future of Motherhood, London: Pandora Press.
12. Keenan, K.L., Basso, D., Goldkrand, J., Butler, W.J. (1991). Low level of maternal serum α-fetoprotein: its associated anxiety and the effects of genetic counseling, Am. J. Obstet. Gynecol., 164, 54-56.
13. Kornman, L.H., Beekhuis, J.R., Mantingh, A., Morssink, L.P. (1995). Serum screening for fetal Down's syndrome of pregnant women with an indication for prenatal diagnosis because of age: fewer amniocenteses, Ned. Tijdschr. Geneeskd., 139, 1840-1844.
14. Kuliev, A., Jackson, L., Froster, U., Brambati, B., Simpson, J.L., Verlinsky, Y., Ginsberg, N., Smidt-Jensen, S., Zakut, H. (1996). Chorionic villus sampling safety, Am. J. Obstet. Gynecol., 174, 807-811.
15. Lawson, H.L., Frye, A., Atrash, H.K., Smith, J.C., Shulman, H.B., Ramick, M. (1994). Abortion mortality, United States, 1972 through 1987, Am. J. Obstet. Gynecol., 171, 1365-1372.
16. Macintosh, M.C.M., Wald, N.J., Chard, T., Hansen, J., Mikkelsen, M., Therkelsen, A.J., Petersen, G.B., Lundsteen, C. (1995). Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older, Br. J. Obstet. Gynaecol., 102, 798-801.
17. Mantingh, A. (1988). On CVS. Early experience with chorionic villus sampling (CVS) in the north of The Netherlands, Thesis, Knoop, Haren.
18. Marteau, T. (1993). Psychological consequences of screening for Down's syndrome, Br. Med. J., 307, 146.
19. Marteau, T.M., Cook, R., Kidd, J., Michie, S., Johnston, M., Slack, J., Shaw, R.W. (1992). The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study, Prenat. Diagn., 12, 205-214.
20. Merkatz, I.R., Nitowsky, H.M., Macri, J.N., Johnson, W.E. (1984). An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities, Am. J. Obstet. Gynecol., 148, 886-894.
21. Muller, F., Cuckle, H., Teisner, B., Grudzinskas, J.G. (1993). Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy, Prenat. Diagn., 13, 633-636.
22. Nicolaides, K., Brizot, M. de L., Patel, F., Snijders, R. (1994). Comparison of chorionic villous sampling and amniocentesis for fetal karyotype at 10-13 weeks' gestation, Lancet, 344, 435-439.
23. Roelofsen, E.E.C., Kamerbeek, L.I., Tijmstra, Tj. (1993a). Chances and choices. Psycho-social consequences of maternal serum screening. A report from The Netherlands, J. Reprod. Infant Psychol., 11, 41-47.
24. Roelofsen, E.E.C., Kamerbeek, L.I., Tijmstra, Tj., Beekhuis, J.R., Mantingh, A. (1993b). Women's opinions on the offer and use of maternal serum screening, Prenat. Diagn., 13, 741-747.
25. Salonen, R., Kurki, L., Lappalainen, M. (1996). Experiences of mothers participating in maternal serum screening for Down's syndrome, Eur. J. Hum. Genet., 4, 113-119.
26. Searle, J. (1996). Fearing the worst - why do pregnant women feel 'at risk'?, Aust. NZ J. Obstet. Gynaecol., 36, 279-286.
27. Spencer, J.W., Cox, D.N. (1987). Emotional responses of pregnant women to chorionic villi sampling or amniocentesis, Am. J. Obstet. Gynecol., 157, 1155-1160.
28. Statham, H., Green, J. (1993). Serum screening for Down's syndrome: some women's experiences, Br Med. J., 307, 174-176.
29. Turnbull, A.C., MacKenzie, I.Z. (1983). Second trimester amniocentesis and termination of pregnancy, Br. Med. Bull., 39, 315-321.
30. van Lith, J.M.M. (1994). First trimester screening for Down's syndrome, Thesis, Rodopi, Amsterdam.
31. Wald, N.J., Hackshaw, A., Stone, R., Densem, J. (1993). Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy, Prenat. Diagn., 13, 1047-1050.
32. Wald, N.J., Kennard, A., Hackshaw, A.K. (1995). First trimester serum screening for Down's syndrome, Prenat. Diagn., 15, 1227-1240.
33. Wald, N.J., George, L., Smith, D., Densem, J.W., Petterson, K., on behalf of the International Prenatal Screening Research Group (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy, Br. J. Obstet. Gynaecol., 103, 407-412.
34. Westergaard, J.G., Teisner, B., Sinosich, M.J., Madsen, L.T., Grudzinskas, J.G. (1985). Does ultrasound examination render biochemical tests obsolete in the prediction of early pregnancy failure?, Br. J. Obstet. Gynaecol., 92, 77-83.
35. Wilson, R.D. (1995). Early amniocentesis: a clinical review, Prenat. Diagn., 15, 1259-1273.